Status:
UNKNOWN
Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention
Lead Sponsor:
Hallym University Kangnam Sacred Heart Hospital
Conditions:
Intense Pulsed Light
Erbium-yttrium Aluminum Garnet Laser
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The scar site was divided into 3 sites; combined IPL/fractional Er:YAG laser treatment site, fractional Er:YAG laser treatment site and untreated control site. At baseline, three lesions were randomiz...
Eligibility Criteria
Inclusion
- Clinical diagnosis of postoperative scars on the abdomen
- scars were symmetrical shaped in a line of 3cm or more
Exclusion
- uncontrolled systemic or chronic disease
- hypersensitive to the ingredients
- a history of other laser treatments within the past 6 months
- pregnancy
- lactation
- Recent sun exposure
Key Trial Info
Start Date :
January 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 14 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04722705
Start Date
January 6 2020
End Date
November 14 2021
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kangnam Sacred Heart Hospital
Seoul, South Korea, 07441